Compounds > 9-aminocamptothecin
Page last updated: 2024-08-25

9-aminocamptothecin and Urinary Bladder Neoplasms

9-aminocamptothecin has been researched along with Urinary Bladder Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dillahey, D; El-Galley, RE; Gomaa, A; Graham, SD; Keane, TE; McGuire, WP; Petros, JA; Sun, C1
Firby, PS; Horn, L; Li, ML; Moore, MJ1

Other Studies

2 other study(ies) available for 9-aminocamptothecin and Urinary Bladder Neoplasms

ArticleYear
Camptothecin analogues/cisplatin: an effective treatment of advanced bladder cancer in a preclinical in vivo model system.
    The Journal of urology, 1998, Volume: 160, Issue:1

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Drug Screening Assays, Antitumor; Humans; Irinotecan; Mice; Mice, Inbred BALB C; Neoplasm Staging; Tumor Cells, Cultured; Urinary Bladder Neoplasms

1998
Pharmacological determinants of 9-aminocamptothecin cytotoxicity.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:1

    Topics: Antineoplastic Agents; Breast Neoplasms; Camptothecin; Cell Division; Colonic Neoplasms; Dose-Response Relationship, Drug; Humans; Tumor Cells, Cultured; Urinary Bladder Neoplasms

2001